# Efficacy and Safety of SPD465 in Adults With ADHD

> **NCT00150579** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 240 (—)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate

## Key facts

- **NCT ID:** NCT00150579
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-27
- **Primary completion:** 2005-06-14
- **Final completion:** 2005-06-14
- **Target enrollment:** 240 (—)
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150579, "Efficacy and Safety of SPD465 in Adults With ADHD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00150579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*